Highlights
A collection of news and information related to ImClone Systems Incorporated published by Tribune Company sources.
Displaying items 1-12 of 170
» View newsday.com items only
1
2
3
4
5
6
7
8
9
10
11-15
•
Next >
-
On this day in history
On Oct. 15, 1844, philosopher Friedrich Nietzsche was born in Rocken in present-day Germany. In 1860 11-year-old Grace Bedell of Westfield, N.Y., wrote to presidential candidate Abraham Lincoln, suggesting he could improve his appearance by growing a...Tags: New York, National Government, Edmonton Oilers, Gordie Howe, Los Angeles Kings
-
Eli Lilly agrees to buy ImClone for more than $6B
The drugmaker Eli Lilly & Co. says it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments. Indianapolis-based Lilly said Monday it will pay $70 per share...Tags: Health Treatments, New York, Bristol Myers Squibb Company, Lilly Eli & Co, Biotechnology Industry
-
IN BRIEF
eBay will cut about 1,600 jobs, 10 percent of its workforce, in its largest round of dismissals ever, the company said yesterday. Chief executive John Donahoe said the cuts were not a reaction to the weak economy; the auction site had been weighing the...Tags: Western Medicines, Timonium, Radio Industry, Labor Legislation, Manhattan (New York City)
-
Buyout details
ASSOCIATED PRESSIndianapolis-based Eli Lilly & Co. is buying ImClone Systems Inc., the biotechnology company controlled by billionaire Carl Icahn. WHO GETS WHAT •Lilly would boost its cancer portfolio, which contains the drugs Alimta and Gemzar, by gaining...Tags: Bristol Myers Squibb Company, Western Medicines, Lilly Eli & Co, Medicine, Biotechnology Industry
-
Lilly looking to its future in $6 billion ImClone deal
From Chicago Tribune news servicesEli Lilly & Co.'s winning bid of more than $6 billion for cancer drug-maker ImClone Systems Inc. means a billion-dollar payday for former rival bidder Bristol-Myers Squibb Co. and vindication for billionaire investor and ImClone Chairman Carl Icahn....Tags: Merck & Company Incorporated, Sales, Pharmaceuticals, New York, Bristol Myers Squibb Company
-
Business Briefing - October 7, 2008
ELI LILLY ACQUIRES IMCLONE FOR $6 BILLION INDIANAPOLIS | Eli Lilly & Co.'s winning bid of more than $6 billion for cancer drugmaker ImClone Systems. Lilly said Monday it would pay $70 per share for the New York-based company. Lilly's bid topped two...Tags: New York, Bristol Myers Squibb Company, Auction Service, Daimler AG, Vehicles
-
Melbourne airport in talks with plane maker
Melbourne International Airport said Monday it is negotiating with a fledgling private-airplane manufacturer, though the company wants local and state incentives before committing to a facility in Brevard County. Melbourne said it is in talks with Comp...Tags: Health Treatments, New York, Bristol Myers Squibb Company, Brevard County, Armed Forces
-
Mystery company expected to make final offer for ImClone
ImClone Systems Inc. said Monday it expects either a solid purchase proposal or formal rejection by Wednesday night from its mystery suitor, which ImClone says is offering $70 per share for the biotech company. That price, from a large pharmaceutical...Tags: Pharmaceuticals, Bristol Myers Squibb Company
-
Report: ImClone's secret suitor is Eli Lilly; drugmaker declines to comment
AP Business WritersINDIANAPOLIS (AP) _ Drugmaker Eli Lilly & Co. reportedly is the secret suitor that's been courting ImClone Systems Inc. and is offering about $6.1 billion for the biotech company. Indianapolis-based Lilly is in advanced talks about the deal, the Wall...Tags: Sales, Pharmaceuticals, Cancer, Bristol Myers Squibb Company, Western Medicines
-
The markets in 60 seconds
Buffett investing billions in Goldman Warren Buffett's Berkshire Hathaway Inc. is investing at least $5 billion in Goldman Sachs, a huge vote of confidence for one of the survivors of the credit crisis that felled two of its investment-banking peers....Tags: Miley Cyrus, Bristol Myers Squibb Company, CVS Corporation, Stock Market, Longs Drug Stores Corporation
-
Bristol-Myers Squibb's bid for ImClone stands despite suitor talk
Bristol-Myers Squibb Co. reiterated its $60-per-share offer for ImClone Systems Inc., even though the biotechnology company has said a secret suitor is offering $10 a share more. The drugmaker is part of a partnership to sell ImClone's only product,...Tags: Sales, Pharmaceuticals, Bristol Myers Squibb Company, Western Medicines, Leveraged Buyouts
-
ImClone, Bristol-Myers
Drug developer Bristol-Myers Squibb Co. offered $4.5 billion in cash for its cancer drug partner ImClone Systems Inc. Thursday, though the biotechnology company's board has yet to comment on the proposal. The offer, for $60 per share, marks a 30...Tags: Cancer, New York, Bristol Myers Squibb Company, Western Medicines, Biotechnology Industry
Oct 15, 2008
|Story| Chicago Tribune
Oct 6, 2008
|Story| Newsday
Oct 7, 2008
|Story| Newsday
Oct 7, 2008
|Story| Chicago Tribune
Oct 7, 2008
|Story| Chicago Tribune
Oct 7, 2008
|Story| Allentown Morning Call
Oct 7, 2008
|Story| Orlando Sentinel
Sep 30, 2008
|Story| Hampton Roads Daily Press
Oct 1, 2008
|Story| Associated Press
Sep 24, 2008
|Story| Orlando Sentinel
Sep 12, 2008
|Story| Chicago Tribune
Jul 31, 2008
|Story| Chicago Tribune
